Impact of GLP-1 Receptor Agonists on Cardiovascular and Kidney Outcomes Across BMI Categories in Type 2 Diabetes
In a groundbreaking cohort study published in JAMA Network Open, researchers have unveiled compelling evidence underscoring the nuanced cardiovascular and ...
